This 54-year-old female is happy. Rightfully so. She has been pulled from the grave.
5 months ago she was handed a death sentence, ALS (Lou
Gehrig’s disease), the worst kind at that.
She found she suddenly had trouble speaking, becoming hoarse then losing
the ability to talk. Shortly thereafter she found it hard to swallow. She lost
weight. She developed weakness of the right upper and left lower extremities.
She went to a neurology clinic at a famous tertiary care center. She was diagnosed with bulbar ALS, a most
severe and deadly form. The expectation was that she would need a feeding tube
followed by ventilator. The doctors at the clinic continued to follow her
downhill course over a three-month period. An EMG test showed the expected
motor neuron denervation. The patient
reported an ultrasound exam of superficial nerves showed nerve swelling rather
than atrophy as expected. Scratching
collective heads, the neurology team decided to do a lumbar puncture. Lyme was
considered. The endorsed DNA/PCR test was negative. One of her doctors ordered a non-sanctioned
test: Lyme Western Blot antibodies in
the CSF. The result was positive. A blood test for Lyme (ELISA first) was
negative. Nonetheless, she was referred
to an ID doctor who was sufficiently impressed to prescribed IV Rocephin. After
2 weeks routine monitoring showed an elevation of the kidney function tests,
BUN and creatinine and antibiotics were discontinued, despite the fact that she
had already responded favorably to the 2-week course of treatment. She told me her neurologists, expecting rapid
deterioration, were recently surprised to see her walk into their office under
her own power. This was the point at which I met her.
When I first met her (6 weeks ago) she could barely eke out a few unintelligible vocalizations. She coughed constantly (due to aspiration secondary to inability to swallow I suspected). She had other limb weakness and joint pain and swelling.
She had lost 15 pounds and was clinically dehydrated, not in
renal failure. Patients with neurological dysphagia (impaired swallowing) have
trouble swallowing “thin” water. Per my
recommendation, with the addition of thickener to fluids, she was able to
hydrate well and the kidney tests normalized.
After 6 weeks of IV antibiotics, our second visit, she spoke
with me with a very hoarse, gravelly but also very intelligible voice. She was
no longer coughing. She was getting stronger and becoming more active day by
day. During examinations she evinced typical neurological signs associated with ALS, including: hyperreflexia, weakness and abnormal reflexes (Hoffman and Babinsky).
Her illness also encompassed my other typical Lyme features:
Brain fog, joint pain, night sweats and
air hunger. These symptoms were in
various stages of getting better.
Lab results: Positive Lyme Western Blot IgG, 8/10 bands MDL,
Giemsa blood smear positive for parasites (presumptive Babesia).
More of the story unraveled. She lives in the country near Frederick
Maryland. She loves to garden. She also is an avid camper in Southern
Maryland. She recalls finding a red
patch on her right forearm 2 years which went away with the application of
cortisone, given the diagnosis eczema.
She went back to the original neurology clinic and was told
that she should only get 28 days of Rocephin based on CDC guidelines. She also patient sought the opinion of another
University based neurologist who said keep treating for Lyme.
Motor neuron disease or ALS is a known, albeit extremely rare manifestation of neurological Lyme disease.
Of course there are no guidelines for the management of Lyme induced ALS. I suspect the tertiary care specialists (recommending antibiotics be stopped) were extrapolating from obsolete IDSA guidelines, predicated on the belief that Borrelia spirochetes do not persist after antibiotic therapy, a thesis that has been thoroughly discredited and longer the dogma of mainstream thinking.
This must stop. Lives are at stake. Health care professionals need to know what Lyme is and what the practice of medicine is.
Lyme is a new and emerging disease, an epidemic of epic proportion with the potential to kill and maim. The clinical manifestations of the disease are protean. The extent and severity of the disease has not been recognized by the medical profession and public health officials. Progress towards a better understanding of the illness has been mired in war of ideas (driven by egos of certain individuals in the academic medical community). Very little research has been done and we sadly know very little about this new disease which reared its ugly head 40 years ago. In a general sense we do not know the optimal therapies for the management of the illness. We know even less about specific variations of therapy which may be optimally effective for the widely divergent clinical presentations of illness.
The practice of medicine is the application of the current iteration of the healing arts as they have evolved over hundreds of years. Today's doctors are better informed (much more is known) than their forbearers of years gone by. By the same token, doctors must be cognizant of the certainty that their future replacements will see them in the same light. The practice of medicine is based on a complex synthesis of science, fact, experience, educated guesses, empiricism, judgement and perhaps philosophy, prescribed by a thoughtful (hopefully intelligent) physician who is committed to his creed and solemn responsibility. My dad (a surgeon) always said medicine is a calling, not a job. A bit preachy, but true.
Lyme patients frequently suffer a slow, smoldering sort of death with a quality of life comparable to that of terminal cancer patients.
Contemporary notions of medicine, created by institutions and corporations demand tangible metrics by which physicians be judged. This may or may not work. Currently the wrong metric is being applied, i.e. following guidelines. This is bean counting. What is important? the patients - of course. This may not be obvious to the institutions that oversee medicine. The primary metric that should be followed is patient outcomes. This is the only useful measure, when the disease, as is the case with Lyme, is complex and poorly understood.
The "system" should learn from doctors who make their patients better, not condemn them, as is frequently the case.